Levoglucosenone

CAS No. 37112-31-5

Levoglucosenone( —— )

Catalog No. M24331 CAS No. 37112-31-5

Levoglucosenone has cytotoxic. It against human hepatocarcinoma cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
10MG 29 In Stock
25MG 40 In Stock
50MG 55 In Stock
100MG 77 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Levoglucosenone
  • Note
    Research use only, not for human use.
  • Brief Description
    Levoglucosenone has cytotoxic. It against human hepatocarcinoma cell lines.
  • Description
    Levoglucosenone has cytotoxic. It against human hepatocarcinoma cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    37112-31-5
  • Formula Weight
    126.11
  • Molecular Formula
    C6H6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    O=C1C=C[C@@]2([H])CO[C@]1([H])O2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sarnik J, Czubatka-Bienkowska A, Macieja A, Bielski R, Witczak ZJ, Poplawski T. The induction of oxidative stress in cervix carcinoma cells by levoglucosenone derived 4-S-salicyl derivative and (1-4)-S-thio-disaccharides. Part 4. Bioorg Med Chem Lett. 2017 Mar 1;27(5):1215-1219. doi: 10.1016/j.bmcl.2017.01.064. Epub 2017 Jan 22. PubMed PMID: 28185719.
molnova catalog
related products
  • Centhaquine

    Centhaquine is an adrenergic receptor potentially for the treatment of postoperative pain and for the resuscitation of hypovolemic shock.

  • HBED

    HBED is an iron chelator and can be used in research on the treatment of chronic iron overload and acute iron poisoning.

  • Monatepil maleate

    Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity.